Table 2.
Clinical characteristics of admitted patients with PIVC phlebitis at University of Gondar hospital, Northwest Ethiopia, April 1, 2020 to August 31, 2020
| Variables | Frequency (No.) | Percentage (%) |
|---|---|---|
| Admission diagnosis | ||
| Lung disease | 97 | 25.3 |
| Heart disease | 68 | 17.7 |
| CNS disease | 65 | 16.9 |
| Chronic liver disease | 21 | 5.5 |
| Chronic kidney disease | 16 | 4.1 |
| Hematological disorders | 18 | 4.7 |
| Fracture | 13 | 3.4 |
| Others | 86 | 22.4 |
| Performance level on admission | ||
| Ambulatory | 68 | 17.7 |
| Semi-ambulatory | 241 | 62.8 |
| Bedridden | 75 | 19.5 |
| Duration of hospital stay (days) | ||
| < 3 | 26 | 6.8 |
| 3–7 | 120 | 31.2 |
| 7–14 | 161 | 41.9 |
| > 14 | 77 | 20.1 |
| Procedure place | ||
| Emergency unit | 203 | 52.9 |
| Wards | 181 | 47.1 |
| Catheter dwell time (days) | ||
| < 3 | 171 | 31.3 |
| 3–4 | 83 | 21.7 |
| > 4 | 130 | 33.9 |
| Cannula insertion site | ||
| Dorsum of hand | 148 | 38.5 |
| Forearm | 201 | 52.3 |
| Antecubital fossa | 35 | 9.2 |
| Catheter size (gauge) | ||
| 18 | 61 | 15.9 |
| 20 | 311 | 81.0 |
| 22 | 8 | 2.1 |
| 24 | 4 | 1.0 |
| IV drugs use | ||
| Yes | 282 | 73.4 |
| No | 102 | 26.6 |
| Infusates use | ||
| Yes | 251 | 65.4 |
| No | 133 | 34.6 |
| Blood products use | ||
| Yes | 52 | 13.5 |
| No | 332 | 86.2 |
NB Others * Osteomyelitis, Bowel obstruction, PIVC peripheral intravenous catheter, IV intravenous